Business Development Strategy

Methapharm's business strategy is to build a portfolio of niche specialty pharmaceutical products and medical devices through:

  • leveraging our existing infrastructure against the distribution of third-party products in either Canada or the United States
  • the acquisition or in-licensing of specialty, niche or under-promoted products from other companies in any therapeutic area
  • the development of further proprietary products and the extension of present product lines

Additionally, Methapharm's European affiliate is seeking distributors in markets outside of North America for specific product opportunities. To contact our Methapharm Europe affiliate visit our contact us page.

Our Business Development activities are divided into three areas:

  1. In-Licensing
  2. Distribution of Third-Party Products
  3. Export Opportunities